386 related articles for article (PubMed ID: 17105223)
1. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
[TBL] [Abstract][Full Text] [Related]
2. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
3. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
4. PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida.
Zhang L; Liu M; Jamil S; Han R; Xu G; Ni Y
Cancer Lett; 2015 Feb; 357(1):346-354. PubMed ID: 25462857
[TBL] [Abstract][Full Text] [Related]
5. Rapid evolution of arginine deiminase for improved anti-tumor activity.
Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
Dillon BJ; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA
Med Sci Monit; 2002 Jul; 8(7):BR248-53. PubMed ID: 12118186
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism.
Das K; Butler GH; Kwiatkowski V; Clark AD; Yadav P; Arnold E
Structure; 2004 Apr; 12(4):657-67. PubMed ID: 15062088
[TBL] [Abstract][Full Text] [Related]
8. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21.
Kim JE; Jeong DW; Lee HJ
Protein Expr Purif; 2007 May; 53(1):9-15. PubMed ID: 17223359
[TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
[TBL] [Abstract][Full Text] [Related]
11. Insight into the catalytic mechanism of arginine deiminase: functional studies on the crucial sites.
Wei Y; Zhou H; Sun Y; He Y; Luo Y
Proteins; 2007 Feb; 66(3):740-50. PubMed ID: 17080455
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
Glazer ES; Piccirillo M; Albino V; Di Giacomo R; Palaia R; Mastro AA; Beneduce G; Castello G; De Rosa V; Petrillo A; Ascierto PA; Curley SA; Izzo F
J Clin Oncol; 2010 May; 28(13):2220-6. PubMed ID: 20351325
[TBL] [Abstract][Full Text] [Related]
13. Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers.
Shen LJ; Shen WC
Curr Opin Mol Ther; 2006 Jun; 8(3):240-8. PubMed ID: 16774044
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties.
Holtsberg FW; Ensor CM; Steiner MR; Bomalaski JS; Clark MA
J Control Release; 2002 Apr; 80(1-3):259-71. PubMed ID: 11943403
[TBL] [Abstract][Full Text] [Related]
15. Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Curley SA; Bomalaski JS; Ensor CM; Holtsberg FW; Clark MA
Hepatogastroenterology; 2003; 50(53):1214-6. PubMed ID: 14571701
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.
Bowles TL; Kim R; Galante J; Parsons CM; Virudachalam S; Kung HJ; Bold RJ
Int J Cancer; 2008 Oct; 123(8):1950-5. PubMed ID: 18661517
[TBL] [Abstract][Full Text] [Related]
17. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
[TBL] [Abstract][Full Text] [Related]
18. Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins.
Zhao H; Yang K; Martinez A; Basu A; Chintala R; Liu HC; Janjua A; Wang M; Filpula D
Bioconjug Chem; 2006; 17(2):341-51. PubMed ID: 16536464
[TBL] [Abstract][Full Text] [Related]
19. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
Ascierto PA; Scala S; Castello G; Daponte A; Simeone E; Ottaiano A; Beneduce G; De Rosa V; Izzo F; Melucci MT; Ensor CM; Prestayko AW; Holtsberg FW; Bomalaski JS; Clark MA; Savaraj N; Feun LG; Logan TF
J Clin Oncol; 2005 Oct; 23(30):7660-8. PubMed ID: 16234528
[TBL] [Abstract][Full Text] [Related]
20. Enhanced pharmacological activity of recombinant human interleukin-11 (rhIL11) by chemical modification with polyethylene glycol.
Takagi A; Yamashita N; Yoshioka T; Takaishi Y; Sano K; Yamaguchi H; Maeda A; Saito K; Takakura Y; Hashida M
J Control Release; 2007 Jun; 119(3):271-8. PubMed ID: 17490774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
